Highlights MorphoSys AG

Equities

Real-time Estimate Tradegate Other stock markets 10:43:12 2024-05-08 EDT			5-day change	1st Jan Change
66.78 ^EUR	-0.04%		+1.13%	+96.62%

05-06	MORPHOSYS : UBS reiterates its Neutral rating	ZD
04-30	European Equities Traded in the US as American Depositary Receipts Decline	MT

European Equities Traded in the US as American Depositary Receipts Decline	04-30	MT
MorphoSys AG Reports Earnings Results for the First Quarter Ended March 31, 2024	04-30	CI
Novartis target Morphosys multiplies losses - takeover schedule stands	04-29	DP
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Monday Trading	04-29	MT
Morphosys says takeover by Novartis on course after report of drug safety concern	04-29	RE
Health Care Slips on Risk Bias -- Health Care Roundup	04-11	DJ
Trending : Novartis Begins Tender Offer for MorphoSys Shares	04-11	DJ
Novartis: MorphoSys Board recommends tender offer	04-11	CF
MorphoSys Board Supports Norvartis' Buyout Offer as Tender Period Begins	04-11	MT
Morphosys management bodies recommend acceptance of Novartis takeover bid	04-11	DP
Novartis begins tender offer for cancer-focused MorphoSys	04-11	RE
Novartis Launches Tender Offer for Germany's MorphoSys	04-11	MT
Novartis initiates tender offer for MorphoSys	04-11	CF
Novartis begins tender offer for cancer-focused MorphoSys	04-11	RE
MorphoSys Gets US Antitrust Approval for Proposed Acquisition by Novartis	03-22	MT
Novartis' EUR2.7 Billion Purchase of MorphoSys Secures US Antitrust Clearance	03-22	MT
Morphosys sees no obstacle on its way under the Novartis umbrella	03-14	DP
MorphoSys Q4 EPS, Revenue Decrease	03-13	MT
Morphosys with higher loss - takeover process by Novartis going according to plan	03-13	DP
MorphoSys AG Reports Earnings Results for the Full Year Ended December 31, 2023	03-13	CI

No results for this search